Cloudbreak Pharma Inc Sustainability Reports
Cloudbreak Pharma Inc. is a clinical-stage biotechnology company that researches and develops ophthalmic drugs. The company leverages its proprietary platform to create first-in-class and best-in-class topical treatments for chronic ocular diseases.
Sector: Manufacturing
Country: United States
Exchange: Hong Kong Stock Exchange
FIGI: BBG01VR6QN35
2 reports from 2025 to 2025
